Why Our Speakers Are Excited About Cannabinoid Derived Pharmaceuticals Summit Europe

Arnold Lippa
CEO and Co-Founder
RespireRx Pharmaceuticals

Arnold Lippa - Speaker

"The Summit provides the invaluable opportunity to engage in thought provoking dialogue with others in order to better understand the issues in the pharmaceutical cannabinoid industry."

"I believe this conference will allow us insight into the future of drug development geared toward the endocannabinoid system and cannabinoid therapeutics, and hopefully highlight current research efforts to better understand practical applications of cannabinoid therapeutics."

Jahan Marcu

Jahan Marcu
International Research Center on Cannabis and Health



Brian Murphy
Emerald Bioscience

Brian Murphy

"The ability to reach a broader audience with our message outside of North America, especially as cannabinoid research is now a global phenomenon."

"The market is evolving at an ever-increasing pace. If the industry is struggling to find its feet then for consumers the world of cannabis is a minefield. As industry leaders, it’s our duty to work towards the creation of a simplified environment for consumers. Meetings such as this provide a potential platform to bring stakeholders together for that common cause."

Speaker - Clifton Flack

Clifton Flack
CEO & Co-Founder



Mauro Maccarrone
Professor & Chair of Biochemistry and Molecular Biology
University of Rome


Mauro Maccarrone - Speaker

"I believe that it is a real plus to put together basic scientists, medical doctors, producers and developers of cannabis-extracts as novel therapeutics, letting patients be part of the progress that the field is making at an amazing speed."

Want to find out more?